thiazolyl blue has been researched along with Di Guglielmo Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benfica, PL; de Lima, AP; dos Santos, WB; Lacerda, Ede P; Mello, FM; Pavanin, LA; Pereira, Fde C; Ribeiro, Ade S; Valadares, MC; Vilanova-Costa, CA | 1 |
Flynn, KM; Fornelli, F; Minervini, F | 1 |
Hildebrandt, A; Lawen, A; Schwabe, K; Steinheider, G; Traber, R | 1 |
3 other study(ies) available for thiazolyl blue and Di Guglielmo Disease
Article | Year |
---|---|
The compound cis-(dichloro)tetrammineruthenium(III) chloride induces caspase-mediated apoptosis in K562 cells.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle; Cell Survival; Cyclosporine; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Ruthenium Compounds; Tetrazolium Salts; Thiazoles; Trypan Blue; Tumor Stem Cell Assay | 2010 |
Toxicity and apoptosis induced by the mycotoxins nivalenol, deoxynivalenol and fumonisin B1 in a human erythroleukemia cell line.
Topics: Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Differentiation; Cell Division; Cell Membrane; Cell Physiological Phenomena; Cell Survival; Cycloheximide; DNA Replication; Dose-Response Relationship, Drug; Flow Cytometry; Fumonisins; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Mitochondria; Mycotoxins; Tetrazolium Salts; Thiazoles; Trichothecenes; Trypan Blue | 2004 |
Reversal of multidrug resistance by novel cyclosporin A analogues and the cyclopeptolide SDZ 214-103 biosynthesized in vitro.
Topics: Cyclosporins; Dactinomycin; Doxorubicin; Drug Interactions; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Friend murine leukemia virus; Humans; Immunosuppressive Agents; Leukemia, Erythroblastic, Acute; Lymphoma; Rhodamine 123; Rhodamines; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1995 |